Israel Secondary Fund (ISF)
Israel Secondary Fund ("ISF") acquires interests in Israel related funds and private companies from investors, founders and employees. Since the inception of the secondary market in Israel in 1998, ISF's partners have played a major role in it, executing dozens of transactions. Our investment professionals have experience in a broad range of secondary transactions as well as hands on experience as partners in venture capital and private equity firms. We have collaborated with the majority of PE and VC funds active in Israel, international & Israeli institutions and have formed close relationships with employees, founders and managers of companies. We believe in the value ISF brings to stakeholders in the Venture Capital and Private Equity community. Creative, discrete and straightforward with a view for long term partnerships and growth, is our way of doing business. What We do: Limited Partners Positions - ISF acquires Limited Partners interests in Israel related VC & PE funds with diversified portfolios. We tailor the transaction to suit the requirements of the sellers and assume future capital commitments. Secondary Direct - ISF acquires interests in Israel-related private companies and portfolios. Sellers include funds, investors, founders and employees. When needed we create Special Purpose Vehicles together with existing GPs or Managers. Structured Secondaries - ISF provides customized solutions, to provide additional capital to Funds and to Limited Partners seeking to reduce risk. When needed we work with fund management and LPs to construct annex funds or other special vehicles.
V-Wave is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave has developed a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity, and improve the overall quality of life. The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing, and bringing to market multiple implantable cardiovascular devices.
Eyeview is a video advertising technology company providing brands with ROI on their video advertising spend. The company’s VideoIQ platform infuses consumer, brand, and retail data into a results-driven decision engine to programmatically deliver 1-to-1 personalized video. VideoIQ provides access to highly viewable and guaranteed fraud-free inventory across television, desktop, tablet, and mobile.Eyeview's platform can be provided as a managed service by Eyeview’s team of analysts, video producers, and campaign experts or through a self-service interface. Headquartered in New York City, with offices in LA, Detroit, Seattle, Chicago, and London, Eyeview serves the nation’s top brands, including P&G, Walgreens, Lowes, Honda, BMW, and Priceline. Eyeview was ranked as the second-fastest growing company in the Tri-State Area by Deloitte’s Technology Fast 500.
V-Wave is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave has developed a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity, and improve the overall quality of life. The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing, and bringing to market multiple implantable cardiovascular devices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.